Amneal's bla submissions for two denosumab biosimilars accepted for review by u.s. fda

Bridgewater, n.j.--(business wire)--amneal's bla submissions for two denosumab biosimilars accepted for review by u.s. fda.
AMRX Ratings Summary
AMRX Quant Ranking